Is LABT up or down today?
LABT is up 15.96% today, last at 2.18. This stock moved +15.96% versus the prior close.
LABT · LABT
LABT (LABT) is trading at 2.18, up 15.96% on the session. LABT carries a 14-day RSI of 43, and trades below its 50-day average. Over the past month it is down 1.80%.
Leading the coverage: “LABT Price Today: Lakewood-Amedex Biotherapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC” (Google News Company, 5d ago). LABT is +2.11% since story.
LABT trades on a trailing P/E of 20.8 and is running 0.86% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
LABT is up 15.96% today, last at 2.18. This stock moved +15.96% versus the prior close.
Leading the coverage: “LABT Price Today: Lakewood-Amedex Biotherapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC” (Google News Company, 5d ago). LABT is +2.11% since story. Dominant story: Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference (1 source, neutral) RSI is 43 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Apr 2026 – Sep 2026 (96 days) · Drag or scroll left for earlier dates
Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Lakewood-Amedex Biotherapeutics Inc. Common Stock (NASDAQ: LABT) Stock Price, News & Analysis - Kalkine
LABT Price Today: Lakewood-Amedex Biotherapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC
LABT: Advancing Toward Phase 2a Study of Nu-3 in Infected Diabetic Foot Ulcers
Lakewood-Amedex Biotherapeutics Inc. Common Stock (NASDAQ: LABT) Stock Price, News & Analysis - kalkine.ca